Analysts Express Confidence in Alnylam's Hypertension Drug Despite Mixed Trial Data
benzinga.com
On Sunday, Alnylam Pharmaceuticals Inc. ALNY presented results from the KARDIA-2 Phase 2 study, which evaluated the efficacy and safety of a single subcutaneous dose of…